Billionaire Investor David Einhorn Bets on Beaten-Down Stocks
A seasoned value investor, Einhorn has long hunted bargains where others fear to tread. This article breaks down how ...
When To Use Lifecycle Fund Instead Of Target Date
This piece outlines scenarios where a lifecycle fund may be preferable to a target date fund, helping you tailor your retirement strategy.
23,259 articlesKulicke Soffa Director Sold: What It Means for Investors
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
Celsius Founder Alex Mashinsky Seeks 12-Year Sentence Vacate
Celsius founder Alex Mashinsky has filed to vacate a 12-year crypto fraud sentence, signaling a dramatic turn in a ca...
Jamie Curtis Pays Tribute: Navigating Grief and Finances After a Loved One Passes
When a family loses a loved one, money worries often rise to the surface. This article examines how jamie curtis pays...
Giant Anthropic Files Public: AI Firm Nears $1T Valuation
Anthropic, the Claude-maker, confidentially files to go public, igniting talk of a potential trillion-dollar valuatio...
Precigen (PGEN) Stock Sell: Should You Dump After CFO Sale?
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
Optimistic Case Crypto 2026 Gains Momentum, Bitwise CIO Says
Bitwise CIO Matt Hougan says the crypto winter persists, but fundamentals are strengthening, laying the groundwork fo...
Fresh IPO Signals: Director Buys PBLS Stock—What It Means
A Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
NVIDIA Earnings: What Watch for Feb. 25 Earnings Report
When NVIDIA reports earnings on Feb. 25, investors will scan every line for AI demand signals, margin trends, and gui...
Ai’s Most Explosive Hardware Slows as Demand Cools
The AI hardware boom is fading as demand cools, dragging optical and memory stocks lower and prompting investors to r...
Is Crispr Therapeutics Stock Risky Right Now? A Practical Guide for Investors
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Dave Perrill Sells 175,000 HIVE Shares: What Investors Need
A major director sale in a blockchain-focused company can raise questions about risk and opportunity. This deep dive ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status